ZNF705G: A Potential Drug Target and Biomarker (G100131980)
ZNF705G: A Potential Drug Target and Biomarker
The ZNF705G gene, located on chromosome 16, is a non-coding RNA molecule that has been identified as a potential drug target and biomarker for various diseases. ZNF705G is a key regulator of stem cell proliferation and has been involved in the development and maintenance of various tissues, including neural stem cells, liver cells, and blood cells.
The ZNF705G gene was first identified in the course of a screening experiment for RNA-based diagnostic biomarkers. The ZNF705G gene was found to have a strong positive correlation with the expression of the stem cell marker, DAPI (doublecortin-伪-interactive protein), and the Ki67 protein, which are commonly used as markers of stem cell proliferation and differentiation.
In addition to its potential as a drug target, ZNF705G has also been identified as a potential biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. The ZNF705G gene has been shown to be overexpressed in various diseases, including cancer, and has been associated with increased cancer risk.
The ZNF705G gene has also been shown to be involved in the development and progression of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. Studies have shown that ZNF705G is overexpressed in the brains of individuals with these conditions and that overexpression of the gene has been associated with increased neurodegeneration.
In addition to its association with neurodegenerative diseases, ZNF705G has also been shown to be involved in the development and progression of autoimmune diseases, such as rheumatoid arthritis and multiple sclerosis. Studies have shown that ZNF705G is overexpressed in individuals with these conditions and that overexpression of the gene has been associated with increased autoimmune inflammation.
The potential drug target for ZNF705G is its role as a regulator of stem cell proliferation and its involvement in the development and progression of various diseases. ZNF705G has been shown to be involved in the regulation of stem cell proliferation and has been involved in the development and maintenance of various tissues. In addition, ZNF705G has also been shown to be involved in the regulation of immune cell function and has been involved in the development and progression of autoimmune diseases.
Given its potential as a drug target and biomarker, ZNF705G is an attractive target for further research and development. Further studies are needed to fully understand the role of ZNF705G in the development and progression of various diseases and to determine its potential as a drug. Additionally, further research is needed to determine the mechanisms by which ZNF705G is involved in the regulation of stem cell proliferation and the development and progression of various diseases.
In conclusion, ZNF705G is a non-coding RNA molecule that has been identified as a potential drug target and biomarker for various diseases. ZNF705G is involved in the regulation of stem cell proliferation and has been shown to be involved in the development and progression of various tissues and diseases. Further research is needed to fully understand the role of ZNF705G in the development and progression of these diseases and to determine its potential as a drug.
Protein Name: Zinc Finger Protein 705G
Functions: May be involved in transcriptional regulation
The "ZNF705G Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZNF705G comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
ZNF706 | ZNF707 | ZNF708 | ZNF709 | ZNF71 | ZNF710 | ZNF711 | ZNF713 | ZNF714 | ZNF716 | ZNF717 | ZNF718 | ZNF721 | ZNF723 | ZNF724 | ZNF726 | ZNF727 | ZNF728 | ZNF729 | ZNF730 | ZNF732 | ZNF734P | ZNF735 | ZNF736 | ZNF737 | ZNF738 | ZNF74 | ZNF740 | ZNF746 | ZNF747 | ZNF749 | ZNF750 | ZNF75A | ZNF75CP | ZNF75D | ZNF76 | ZNF761 | ZNF763 | ZNF764 | ZNF765 | ZNF766 | ZNF767P | ZNF768 | ZNF77 | ZNF770 | ZNF771 | ZNF772 | ZNF773 | ZNF774 | ZNF775 | ZNF776 | ZNF777 | ZNF778 | ZNF780A | ZNF780B | ZNF781 | ZNF782 | ZNF783 | ZNF784 | ZNF785 | ZNF786 | ZNF787 | ZNF788P | ZNF789 | ZNF79 | ZNF790 | ZNF790-AS1 | ZNF791 | ZNF792 | ZNF793 | ZNF799 | ZNF8 | ZNF8-ERVK3-1 | ZNF80 | ZNF800 | ZNF804A | ZNF804B | ZNF805 | ZNF807P | ZNF808 | ZNF81 | ZNF812P | ZNF813 | ZNF814 | ZNF815P | ZNF816 | ZNF816-ZNF321P | ZNF818P | ZNF821 | ZNF823 | ZNF826P | ZNF827 | ZNF829 | ZNF83 | ZNF830 | ZNF831 | ZNF833P | ZNF835 | ZNF836 | ZNF837
